New Alzheimer's antibodies: AAIC rings bell for first round face off

Over the last few days, attendees of the ongoing annual meeting of the Alzheimer’s Association have been arriving in Amsterdam for what has turned out to be a particularly exciting congress.

Spared the sweltering heat wave affecting more southerly parts of the continent, a palpably buoyant mood may be detected among conference-goers, as the Alzheimer’s community gets to grips with data showing real progress in the field for the first time in years.

For those focused on the therapy area, medical meetings which break down either promising early research or late-stage failures have become the norm - but a number of key clinical and regulatory breakthroughs have turned the situation around.